Assessment of phenotypic carbapenem susceptibility and genomic epidemiology of Campylobacter from animal, food and human domains – “CarbaCamp”
EFSA Supporting Publications · 01.07.2026 · 23 (7)
DOI: 10.2903/sp.efsa.2026.en-10100 ↗Kurz gefasst
Fachartikel in der Zeitschrift EFSA Supporting Publications, erschienen am 01.07.2026. Verfasst von Elisabeth D. Chang und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Emerging evidence of carbapenem non‐susceptibility led to the EFSA recommendation to include ertapenem in the resistance monitoring of Campylobacter from 2021. The CarbaCamp project investigated carbapenem susceptibility in C. coli and C. jejuni populations from food animal surveillance contexts as well as of human origin. A total of 2,315 isolates from 16 European countries were requested, of which 1,889 were tested by disc diffusion (DD). From these, 600 isolates were selected for minimum inhibitory concentration (MIC) determination and WGS, and 596 passed sequencing Quality Control (QC) for downstream analyses. Overall, DD and MIC data showed no major differences in wild‐type distributions between animal hosts (cattle, pigs, broilers and turkeys), but clear species‐specific differences were observed between Campylobacter species. Ertapenem had broad and bimodal DD and MIC distributions, with substantial overlap between suspected WT and non‐WT populations. A similar but less pronounced pattern was observed for meropenem. For imipenem narrow, unimodal distributions were observed. Correlation analysis demonstrated the strongest association between ertapenem and meropenem zone diameters, whereas correlations with imipenem were weaker, supporting a distinct phenotypic behaviour among the carbapenems included in this study. DD and MIC epidemiological cut‐off values (ECOFFs) could not be established for ertapenem and meropenem due to the bimodal distributions. Imipenem distribution behaved as expected and tentative ECOFFs were established for imipenem in both species (DD 35 mm; MIC 0.25 mg/L). Parallel broth microdilution using EUCAST and CLSI recommended media showed no systematic MIC differences. No clear genetic determinants were identified that could explain the observed carbapenem susceptibility patterns but the chemical structure of the carbapenem likely plays an important role. No definitive recommendation on which carbapenem should be used for monitoring can currently be given, due to the unresolved issues with the ertapenem and meropenem data, although imipenem appears to be the most suitable for interim monitoring.
Schlagwörter
Zitieren
APA
Chang, E. D., Andrea, A., Mourão, J., Akkas, A., Mølnitz, F. H., Lund, B. S. R., Kristensen, T., Larsen, G., Matuschek, E., Kahlmeter, G., & Hendriksen, R. S. (2026). Assessment of phenotypic carbapenem susceptibility and genomic epidemiology of Campylobacter from animal, food and human domains – “CarbaCamp”. EFSA Supporting Publications, 23(7). https://doi.org/10.2903/sp.efsa.2026.en-10100
Vancouver
Chang ED, Andrea A, Mourão J, Akkas A, Mølnitz FH, Lund BSR, et al. Assessment of phenotypic carbapenem susceptibility and genomic epidemiology of Campylobacter from animal, food and human domains – “CarbaCamp”. EFSA Supporting Publications. 2026;23(7). doi:10.2903/sp.efsa.2026.en-10100
BibTeX
@article{Chang2026,
author = {Chang, Elisabeth D. and Andrea, Athina and Mourão, Joana and Akkas, Ayperi and Mølnitz, Freya Helena and Lund, Birthe S. Rosenqvist and Kristensen, Tatjana and Larsen, Gunhild and Matuschek, Erika and Kahlmeter, Gunnar and Hendriksen, René S.},
title = {Assessment of phenotypic carbapenem susceptibility and genomic epidemiology of Campylobacter from animal, food and human domains – “CarbaCamp”},
journal = {EFSA Supporting Publications},
year = {2026},
volume = {23},
number = {7},
doi = {10.2903/sp.efsa.2026.en-10100}
}
EUVIMED